A new study by a research team at Université de Montréal highlights a critical lack of knowledge about the cognitive profiles ...

A major scientific review reveals a deep knowledge gap in how cognition is affected when schizophrenia and personality disorders occur together.

Medication is the default schizophrenia treatment; however, it may not address key symptoms like social and cognitive deficits. Group therapy may be a new, promising intervention.

When I was first diagnosed with schizoaffective disorder in 2017, none of my existing doctors or therapists specialized in schizophrenia disorders. I had a really hard time finding therapies that ...

Atai Life Sciences’ schizophrenia drug has failed to improve cognition in a phase 2 study, leading the biotech to reaffirm that the therapy is no longer a priority. The drug in question, formerly ...

For the past 70 years, schizophrenia treatments all targeted the same chemical: dopamine. While that works for some, it causes brutal side effects for others. An antipsychotic drug approved last month ...

Panelists discuss how digital therapeutics could address the enormous unmet need for treating negative symptoms in the 60% of patients with schizophrenia who experience them, potentially reducing ...

Antibodies from llamas could be used to create a new generation of schizophrenia treatments that can effectively target the brain, rather than just reducing symptoms. This is the promise of a study ...

A cortical neuron treated with JRT, a synthetic molecule similar to the psychedelic drug LSD. Drugs like JRT might enable new treatments for conditions such as schizophrenia, without the ...

Schizotypal personality disorder and schizoaffective disorder are distinct conditions that cause different symptoms. Learn how doctors tell them apart here.